REGEN-COV reduces risk for COVID-19 hospitalization, death
Oct 01, 2021
Among outpatients with COVID-19 at high risk, the risk for hospitalization and death was reduced with the monoclonal antibody combo versus placebo.
mRNA Vaccine more effective booster to ChAdOx1 nCoV-19
Oct 22, 2021
“Our study shows a greater risk reduction for people who received an mRNA vaccine after having received a first dose of a vector-based, as compared to people having received the vector-based vaccine...
Rise in U.K. COVID-19 cases closely watched by U.S. health officials
Mar 15, 2022
The U.K. saw a 48% increase in COVID-19 cases and a 17% rise in hospitalizations last week.
Rising COVID-19 cases in U.S. not yet cause for alarm: Fauci
Apr 11, 2022
There are an average of 31,000 new cases a day nationwide, a 3% increase from two weeks ago.
FDA could approve Pfizer booster shots for all adults this week
Nov 17, 2021
More than 30 million Americans already have gotten booster shots.
FDA questions strength of Johnson & Johnson booster shot data
Oct 13, 2021
The agency says a key test used by the company to measure immune response from booster shot six months after the original shot was likely not sensitive enough.
Immune response may vary with choice of COVID-19 booster
Dec 16, 2021
All seven vaccines tested boosted immunity following two doses of ChAdOx1 nCoV-19; six of seven did so following two doses of BNT162b2.
Scientists spot clues to why omicron infections are milder
Jan 03, 2022
More than a dozen research groups have been observing the omicron variant in lab settings using animals this past month.
Trials show promise for intravitreal faricimab in retinal disease
Feb 02, 2022
Faricimab was noninferior to aflibercept for visual acuity gains in neovascular age-related macular degeneration and diabetic macular edema.
Model predicts impact of food choices on life expectancy
Feb 16, 2022
A change to the optimized diet at age 60 years from a typical diet is estimated to increase LE by 8 years for women and 8.8 years for men, while 80-year-olds could gain about 3.4 years.